CJMB
Callan JMB Inc.1.7700
+0.0600+3.51%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
8.18MP/E (TTM)
-Basic EPS (TTM)
-1.56Dividend Yield
0%Recent Filings
8-K
8-K
10-Q
8-K
8-K
Q2 revenues dip amid expansions
Callan JMB reported Q2 2025 revenues of $1.7 million, down from $2.0 million year-over-year due to softer emergency preparedness demand, while SG&A expenses climbed to $2.0 million from public company costs and hires, yielding a $1.4 million operating loss. Key moves included a Revival partnership for integrated health product supply chains, an India subsidiary launch for cold chain pharma logistics, and a Chicago contract extension adding $1.5 million to reach $9.1 million total through June 2026. Expansion targets GLP-1 drugs and compounding pharmacies. Risks include execution in new markets.
IPO
Website
Employees
Sector
Industry
CCEL
Cryo-Cell International, Inc.
3.80+0.06
CHRW
C.H. Robinson Worldwide, Inc.
159.04+1.43
CTNT
Cheetah Net Supply Chain Servic
1.39+0.00
CVLG
Covenant Logistics Group, Inc.
23.27+0.16
CYRX
CryoPort, Inc.
9.24+0.00
JANL
Janel Corp.
34.00+0.00
JBHT
J.B. Hunt Transport Services, I
196.76-0.84
JYD
Jayud Global Logistics Limited
3.54-0.02
LSTR
Landstar System, Inc.
144.57-1.78
SFWL
Shengfeng Development Limited
1.08+0.28